Effects of clonidine on plasma catecholamines and neuropeptide Y in hypertensive patients at rest and during stress. 1993

L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
Department of Pharmacology and INSERM U337, Broussais Hospital, Paris, France.

Neuropeptide Y (NPY), a potent vasoconstrictor agent reported to be released, in addition to norepinephrine (NE), by sympathetic nerve endings during stress, may contribute to the pressor response to various stimuli. The objectives of this study were to determine (a) whether plasma NPY concentrations are altered during different types of stress (cold pressor test, mental stress, and active orthostatism) and (b) whether clonidine, via its central sympatholytic effect, affects the stress-induced blood pressure, NPY, and/or catecholamine changes. Eighteen untreated patients with mild essential or borderline hypertension participated in an acute randomized, double-blind, parallel study. The blood pressure and heart rate were recorded during three control periods, each followed by either a cold pressor test (CPT), a mental stress test (MS: mental arithmetic), or active orthostatism (AO), performed in a random order. Venous blood samples for catecholamines and NPY determination were taken at the end of each control and test period. This entire procedure was repeated after oral clonidine (150 micrograms) or placebo. Before treatment, a CPT, MS, or AO increased the blood pressure to the same extent. The stress-induced increase in plasma NE was greater during AO (+99 +/- 23%) than during CPT (+35 +/- 8%) and MS (+55 +/- 12%). The stress-induced increase in plasma epinephrine was only significant during MS (+142 +/- 69%). A small but significant increase in NPY (p < 0.05) was observed during AO only (+10 +/- 7%). Compared to placebo, clonidine significantly decreased the basal blood pressure and the pressor response to CPT, but did not change the pressor response to MS and AO.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007024 Hypotension, Orthostatic A significant drop in BLOOD PRESSURE after assuming a standing position. Orthostatic hypotension is a finding, and defined as a 20-mm Hg decrease in systolic pressure or a 10-mm Hg decrease in diastolic pressure 3 minutes after the person has risen from supine to standing. Symptoms generally include DIZZINESS, blurred vision, and SYNCOPE. Hypotension, Postural,Orthostatic Hypotension,Postural Hypotension
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D012146 Rest Freedom from activity. Rests
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold

Related Publications

L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
September 1998, Bollettino chimico farmaceutico,
L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
October 1982, Journal of applied physiology: respiratory, environmental and exercise physiology,
L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
October 1993, Scandinavian journal of clinical and laboratory investigation,
L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
August 1989, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
January 1988, Journal of cardiovascular pharmacology,
L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
January 2001, Psychosomatic medicine,
L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
July 1983, Aviation, space, and environmental medicine,
L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
February 1997, The Journal of thoracic and cardiovascular surgery,
L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
May 1991, Journal of internal medicine,
L Puybasset, and P Lacolley, and S Laurent, and F Mignon, and E Billaud, and J L Cuche, and E Comoy, and M Safar
June 1999, Clinical science (London, England : 1979),
Copied contents to your clipboard!